Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 3,038 shares at $6.63 ($20K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Seasonal sale ($20k) by President and CEO — this insider has traded ATRA in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.63 | 276 | $2K | 9.1% |
| 2 | $6.63 | 2,762 | $18K | 90.9% |
| Total | $6.63 avg | 3,038 | $20K | 100% |
| Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |
| ATRA | SELL | 2023-06-29 | $24K | — | Filing → |